1-17 of 17
Jens Juul Holst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

Jens Juul Holst
Journal: Diabetes
Diabetes 2021;70(11):2468–2475
https://doi.org/10.2337/dbi21-0026
Published: 22 October 2021
View article titled, Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture
Open the PDF for Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture in another window
Journal Articles

Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability

Kirstine N. Bojsen-Møller, Anne-Marie Lundsgaard, Sten Madsbad, Bente Kiens, Jens Juul Holst
Journal: Diabetes
Diabetes 2018;67(11):2129–2136
https://doi.org/10.2337/db18-0539
Published: 11 October 2018
View article titled, Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability
Open the PDF for Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability in another window
Journal Articles

The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor

Meena Asmar, Ali Asmar, Lene Simonsen, Lærke Smidt Gasbjerg, Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Bolette Hartmann, Flemming Dela, Jens Juul Holst, Jens Bülow
Journal: Diabetes
Diabetes 2017;66(9):2363–2371
https://doi.org/10.2337/db17-0480
Published: 30 June 2017
View article titled, The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor
Open the PDF for The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor in another window
Journal Articles

Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

Kristine Færch, Dorte Vistisen, Giovanni Pacini, Signe S. Torekov, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Marit E. Jørgensen, Bo Ahrén, Jens Juul Holst
Journal: Diabetes
Diabetes 2016;65(11):3473–3481
https://doi.org/10.2337/db16-0240
Published: 08 August 2016
View article titled, Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation
Open the PDF for Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation in another window
Journal Articles

Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525

Kristine Færch, Signe S. Torekov, Dorte Vistisen, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Annelli Sandbæk, Jens Juul Holst, Marit E. Jørgensen
Journal: Diabetes
Diabetes 2015;64(9):e30–e31
https://doi.org/10.2337/db15-0743
Published: 13 August 2015
View article titled, Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525
Open the PDF for Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525 in another window
Journal Articles

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

Kristine Færch, Signe S. Torekov, Dorte Vistisen, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Annelli Sandbæk, Jens Juul Holst, Marit E. Jørgensen
Journal: Diabetes
Diabetes 2015;64(7):2513–2525
https://doi.org/10.2337/db14-1751
Published: 12 February 2015
View article titled, GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
Open the PDF for GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study in another window
Includes: Supplementary data
Journal Articles

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1

Jens Juul Holst
Journal: Diabetes
Diabetes 2011;60(9):2203–2205
https://doi.org/10.2337/db11-0798
Published: 20 August 2011
View article titled, Postprandial Insulin Secretion After Gastric Bypass Surgery: <subtitle>The Role of Glucagon-Like Peptide 1</subtitle>
Open the PDF for Postprandial Insulin Secretion After Gastric Bypass Surgery: <subtitle>The Role of Glucagon-Like Peptide 1</subtitle> in another window
Journal Articles

Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans

Meena Asmar, Lene Simonsen, Sten Madsbad, Bente Stallknecht, Jens Juul Holst, Jens Bülow
Journal: Diabetes
Diabetes 2010;59(9):2160–2163
https://doi.org/10.2337/db10-0098
Published: 14 June 2010
View article titled, Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans
Open the PDF for Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans in another window
Journal Articles

Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice

Heidi Sørensen, Christian L. Brand, Susanne Neschen, Jens Juul Holst, Keld Fosgerau, Erica Nishimura, Gerald I. Shulman
Journal: Diabetes
Diabetes 2006;55(10):2843–2848
https://doi.org/10.2337/db06-0222
Published: 01 October 2006
View article titled, Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic <em>ob/ob</em> Mice
Open the PDF for Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic <em>ob/ob</em> Mice in another window
Journal Articles

Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility

Takashi Miki, Kohtaro Minami, Hidehiro Shinozaki, Kimio Matsumura, Atsunori Saraya, Hiroki Ikeda, Yuichiro Yamada, Jens Juul Holst, Susumu Seino
Journal: Diabetes
Diabetes 2005;54(4):1056–1063
https://doi.org/10.2337/diabetes.54.4.1056
Published: 01 April 2005
View article titled, Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility
Open the PDF for Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut Motility in another window
Journal Articles

The Incretin Approach for Diabetes Treatment: Modulation of Islet Hormone Release by GLP-1 Agonism

Jens Juul Holst, Cathrine Ørskov
Journal: Diabetes
Diabetes 2004;53(suppl_3):S197–S204
https://doi.org/10.2337/diabetes.53.suppl_3.S197
Published: 01 December 2004
View article titled, The Incretin Approach for Diabetes Treatment: <subtitle>Modulation of Islet Hormone Release by GLP-1 Agonism</subtitle>
Open the PDF for The Incretin Approach for Diabetes Treatment: <subtitle>Modulation of Islet Hormone Release by GLP-1 Agonism</subtitle> in another window
Journal Articles

Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis

Peter Staehr, Ole Hother-Nielsen, Bernard R. Landau, Visvanathan Chandramouli, Jens Juul Holst, Henning Beck-Nielsen
Journal: Diabetes
Diabetes 2003;52(2):260–267
https://doi.org/10.2337/diabetes.52.2.260
Published: 01 February 2003
View article titled, Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis
Open the PDF for Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis in another window
Journal Articles

Gliclazide Directly Inhibits Arginine-Induced Glucagon Release

Kenan Cejvan, David H. Coy, Jens Juul Holst, Erol Cerasi, Suad Efendic
Journal: Diabetes
Diabetes 2002;51(suppl_3):S381–S384
https://doi.org/10.2337/diabetes.51.2007.S381
Published: 01 December 2002
View article titled, Gliclazide Directly Inhibits Arginine-Induced Glucagon Release
Open the PDF for Gliclazide Directly Inhibits Arginine-Induced Glucagon Release in another window
Journal Articles

Early Differential Defects of Insulin Secretion and Action in 19-Year-Old Caucasian Men Who Had Low Birth Weight

Christine B. Jensen, Heidi Storgaard, Flemming Dela, Jens Juul Holst, Sten Madsbad, Allan A. Vaag
Journal: Diabetes
Diabetes 2002;51(4):1271–1280
https://doi.org/10.2337/diabetes.51.4.1271
Published: 01 April 2002
View article titled, Early Differential Defects of Insulin Secretion and Action in 19-Year-Old Caucasian Men Who Had Low Birth Weight
Open the PDF for Early Differential Defects of Insulin Secretion and Action in 19-Year-Old Caucasian Men Who Had Low Birth Weight in another window
Journal Articles

Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients

Peter Staehr, Ole Hother-Nielsen, Klaus Levin, Jens Juul Holst, Henning Beck-Nielsen
Journal: Diabetes
Diabetes 2001;50(6):1363–1370
https://doi.org/10.2337/diabetes.50.6.1363
Published: 01 June 2001
View article titled, Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients
Open the PDF for Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients in another window
Journal Articles

Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling

Jesper Gromada, Krister Bokvist, Wei-Guang Ding, Jens Juul Holst, Jens Høiriis Nielsen, Patrik Rorsman
Journal: Diabetes
Diabetes 1998;47(1):57–65
https://doi.org/10.2337/diab.47.1.57
Published: 01 January 1998
View article titled, Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling
Open the PDF for Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic β-Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling in another window
Journal Articles

Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion

Niels Pørksen, Thorbjørn Grøfte, Birgit Nyholm, Jens Juul Holst, Steven M Pincus, Johannes D Veldhuis, Ole Schmitz, Peter C Butler
Journal: Diabetes
Diabetes 1998;47(1):45–49
https://doi.org/10.2337/diab.47.1.45
Published: 01 January 1998
View article titled, Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion
Open the PDF for Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion in another window